Founded in 1998, Aldevron creates, develops, manufactures and markets a full line of non-Good Manufacturing Process contract plasmid Deoxyribonucleic acid products and provides numerous related services. The company can also manufacture plasmid DNA under state-of-the-art GMP conditions for clinical applications. The company s core technology is a proprietary method to produce and purify plasmid DNA developed by the company s founders, John Ballantyne and Michael Chambers. Its products include research-and clinical-grade plasmid DNA, GMP-source plasmid DNA, gene therapy plasmids, genetic immunizations and antibodies, HBsAg products, UMVC gene therapy plasmids, gWIZ Reporter plasmids and a complete range of OEM and contract protein services. Aldevron maintains its corporate offices, research and production facilities in Fargo, N.D. and has additional operations in Friedberg, Germany.